ReviewOncology letters2025
Advances in lenvatinib monotherapy and combination therapies in anaplastic thyroid cancer (Review).
Lisha Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewOncology letters2025
Lisha Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.